SG11202105136WA - Application of chidamide - Google Patents
Application of chidamideInfo
- Publication number
- SG11202105136WA SG11202105136WA SG11202105136WA SG11202105136WA SG11202105136WA SG 11202105136W A SG11202105136W A SG 11202105136WA SG 11202105136W A SG11202105136W A SG 11202105136WA SG 11202105136W A SG11202105136W A SG 11202105136WA SG 11202105136W A SG11202105136W A SG 11202105136WA
- Authority
- SG
- Singapore
- Prior art keywords
- chidamide
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811385440 | 2018-11-20 | ||
| PCT/CN2019/119094 WO2020103778A1 (fr) | 2018-11-20 | 2019-11-18 | Application du chidamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105136WA true SG11202105136WA (en) | 2021-06-29 |
Family
ID=70741812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105136WA SG11202105136WA (en) | 2018-11-20 | 2019-11-18 | Application of chidamide |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220000848A1 (fr) |
| EP (1) | EP3884944A4 (fr) |
| JP (1) | JP7489384B2 (fr) |
| KR (1) | KR20210133207A (fr) |
| CN (1) | CN111195251A (fr) |
| AU (1) | AU2019385370B2 (fr) |
| BR (1) | BR112021009608A2 (fr) |
| CA (1) | CA3120206A1 (fr) |
| PH (1) | PH12021551137A1 (fr) |
| SG (1) | SG11202105136WA (fr) |
| TW (1) | TWI781356B (fr) |
| WO (1) | WO2020103778A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4201426A1 (fr) * | 2021-12-23 | 2023-06-28 | Fundació Institut de Recerca Contra la Leucèmia Josep Carreras | Compositions pharmaceutiques pour induire l'expression de hdac7 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103833626B (zh) * | 2012-11-27 | 2015-11-25 | 深圳微芯生物科技有限责任公司 | 西达本胺的晶型及其制备方法与应用 |
| CN104771363A (zh) * | 2014-01-14 | 2015-07-15 | 深圳微芯生物科技有限责任公司 | 一种西达本胺固体分散体及其制备方法与应用 |
| CN104083763A (zh) * | 2014-07-16 | 2014-10-08 | 中国人民解放军军事医学科学院野战输血研究所 | 组蛋白去乙酰化酶抑制剂在制备潜伏病毒激活剂中的应用 |
| TWI794171B (zh) * | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| CA3031365A1 (fr) * | 2016-07-20 | 2018-01-25 | The Trustees Of Columbia University In The City Of New York | Activateurs d'histone acetyltransferase et compositions et utilisations associees |
| CN109371128A (zh) * | 2018-10-22 | 2019-02-22 | 广东省人民医院(广东省医学科学院) | 一种用于检测crebbp基因突变位点的引物及试剂盒和应用 |
-
2019
- 2019-11-18 WO PCT/CN2019/119094 patent/WO2020103778A1/fr not_active Ceased
- 2019-11-18 BR BR112021009608-6A patent/BR112021009608A2/pt not_active Application Discontinuation
- 2019-11-18 CA CA3120206A patent/CA3120206A1/fr active Pending
- 2019-11-18 US US17/295,490 patent/US20220000848A1/en not_active Abandoned
- 2019-11-18 SG SG11202105136WA patent/SG11202105136WA/en unknown
- 2019-11-18 TW TW108141825A patent/TWI781356B/zh active
- 2019-11-18 AU AU2019385370A patent/AU2019385370B2/en active Active
- 2019-11-18 EP EP19887759.9A patent/EP3884944A4/fr not_active Withdrawn
- 2019-11-18 JP JP2021527821A patent/JP7489384B2/ja active Active
- 2019-11-18 CN CN201911129472.6A patent/CN111195251A/zh active Pending
- 2019-11-18 KR KR1020217018969A patent/KR20210133207A/ko not_active Ceased
-
2021
- 2021-05-19 PH PH12021551137A patent/PH12021551137A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020103778A1 (fr) | 2020-05-28 |
| US20220000848A1 (en) | 2022-01-06 |
| AU2019385370A1 (en) | 2021-06-24 |
| KR20210133207A (ko) | 2021-11-05 |
| CN111195251A (zh) | 2020-05-26 |
| AU2019385370B2 (en) | 2025-04-03 |
| TW202031258A (zh) | 2020-09-01 |
| EP3884944A4 (fr) | 2022-08-31 |
| PH12021551137A1 (en) | 2022-02-21 |
| CA3120206A1 (fr) | 2020-05-28 |
| JP2022509100A (ja) | 2022-01-20 |
| BR112021009608A2 (pt) | 2021-08-10 |
| JP7489384B2 (ja) | 2024-05-23 |
| EP3884944A1 (fr) | 2021-09-29 |
| TWI781356B (zh) | 2022-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267828A (en) | A separate configuration of numerologically linked resources | |
| SG11202106378VA (en) | Modulators of hsd17b13 expression | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| SG11202102636UA (en) | Modulators of pnpla3 expression | |
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| IL276592A (en) | History of Subtirum | |
| GB201806072D0 (en) | Methods of manufacture | |
| IL274627A (en) | Solid forms of valbenazine | |
| PT3661491T (pt) | 3-metilmetcatinona para uso no tratamento de um indivíduo sob uma intervenção psicoterapêutica | |
| GB201708457D0 (en) | Inhibitors of metallo-beta-lactamases | |
| GB201700711D0 (en) | Application of an optical effect | |
| ZA201906238B (en) | New therapeutical use of h3-ligands | |
| GB201719639D0 (en) | Setection of biomarkers | |
| IL272857A (en) | Cofanalisib formulations | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| GB201805904D0 (en) | Methods of Manufacture | |
| PT3320901T (pt) | Dimetilaminomicheliolida para utilização no tratamento de fibrose pulmonar | |
| ZA202105399B (en) | Use of spiropidion | |
| IL276107A (en) | Crystalline forms of psoorstam | |
| SG11202105136WA (en) | Application of chidamide | |
| GB201708451D0 (en) | Inhibitors of metallo-beta-lactamases | |
| IL283421A (en) | Crystalline forms of Refroxlap | |
| PT3901141T (pt) | Nova forma de isoquinolinossulfonamida | |
| GB201721386D0 (en) | Chrondogy of time-wave | |
| GB201810835D0 (en) | Methods of use |